Market Need Diabetic foot care is a high-cost, preventable crisis with a large underserved market in hospitals and clinics. Revealix targets early risk detection, presenting a clear value proposition for healthcare providers aiming to reduce amputations and admissions.

Early Prevention The platform emphasizes a 3-minute workflow to screen, document, and stratify risk, enabling hospital systems to intervene before wounds develop. This aligns with payer and provider incentives to improve outcomes at lower costs.

Pilot and Expansion With a small team and startup funding, there is opportunity to partner on pilots within hospital networks, then scale to integrated workflows across departments and facilities seeking standardized diabetic foot risk management.

Technology Fit Existing tech stack leverages cloud infrastructure and common collaboration tools, suggesting easy integration potential with enterprise health IT environments and minimal disruptive implementation for IT teams.

Competitive Positioning Revealix differentiates as a risk-detection platform rather than wound care, creating a niche within the preventive care segment and presenting cross-sell opportunities with larger health tech players serving hospitals and clinics.